Summary. Helicobacter pylori is important in the aetiology of peptic ulceration. Despite inducing an inflammatory response in the mucosa, the organism persists, suggesting that it has efficient protective mechanisms. Some bacterial and viral products modulate histamine secretion from inflammatory cells. Therefore, this study examined the modulatory effects of H. pylori preparations on histamine release from rat peritoneal mast cells and human basophils. Eleven clinical isolates of H. pylori were prepared in different ways: as whole washed bacteria, washed sonicated bacteria, and formalin-killed bacteria, and as outermembrane and lipopolysaccharide (LPS) extracts. Histamine release from mast cells or basophils was not elicited by any of these bacterial preparations alone. However, when mixed with various secretory stimulants, the bacterial preparations caused inhibition of histamine release from rat mast cells (calcium ionophore A23 187, compound 48/80, concanavalin A, anti-rat IgE) and human basophils (A23 187, N-formyl Met-Leu-Phe). The degree of inhibition ranged from 48 YO to 97 YO. These results indicate that H. pylori exerts an inhibitory effect on cells of the immune system that contributes to its persistence within the gastric mucosa.
Introduction
Helicobacter pylori (H. pylori) is recognised as a significant cause of chronic antral gastritis and is important in the aetiology of duodenal ulceration. [1] [2] [3] There is also evidence to support a role for H . pylori as a risk factor for gastric c a r c i n~m a .~-~ The pathogenic mechanisms of H. pylori are incompletely understood. Several of the histological features associated with H . pylori infection (e.g., neutrophil infiltration and increased numbers of mononuclear cells-chiefly lymphocytes and plasma cells) are similar to those observed in human allergic reactions.', * The importance of mast cells and basophils in immediate hypersensitivity reactions (e.g., hay fever, atopic asthma) has long been recognisedg and recent evidence suggests that they may be involved in other disease states involving chronic inflammatory processes.1o Mast cells and basophils may be activated either by immunological mechanisms (via antigen cross-linking of specific IgE bound to the plasma membrane of mast cells and basophils) or via non-immunological pathways, whereby the agent directly activates the cells." Haemophilus influenzae, Salmonella typhimurium and several other bacteria, as well as bacterial and viral products, have been found to induce or modulate histamine release from mast cells or basophils. 12* l3 Duodenal ulcer patients, both children'' and adults,15 with H. pylori infection have a lower concentration of histamine within their oxyntic mucosa than H. pylori-negative patients. This suggests that the mucosal mast cells in the H. pylori-positive patients are either actively secreting histamine, or that histamine synthesis is reduced. Furthermore, basophils from 84% of chronic gastritis patients with H. pylori infection were found to have bound H. pylori-specific IgE, and to release histamine when challenged with surface antigens of H. pylori. Histamine liberation, by an IgE-mediated mechanism, was similarly achieved when normal basophils were passively sensitised with serum from IgE-positive patients. 16 In-vitro studies have shown that washed cells, formalin-killed cells and crude cell-wall preparations of H. pylori were unable to induce histamine release from rat serosal, peritoneal and pleural mast cells. However, similar preparations from several H . pylori strains were found to potentiate mast cell histamine release induced by compound 48/80, calcium Thus, H. pylori may be involved in mast cell and basophil activation and subsequent mediator release. In patients with specific IgE, an antibody-allergen reaction may occur leading to mediator release and the attendant inflammatory response. However, in patients lacking specific IgE, H. pylori products may potentiate the release of mediators from mast cells or basophils which have been primed by other agents. Despite these studies, the precise role of H. pylori in histamine release remains unclear.
The aim of the present study was to investigate further the direct and modulatory actions of H. pylori preparations on rat peritoneal mast cells and human basophils. The effect of H. pylori on mediator release via both IgE-dependent and IgE-independent nonimmunological mechanisms was examined. 
Materials and methods

Isolation
Preparation of bacteria for histamine release experiments
For whole washed H. pylori, bacteria were harvested after 2-3 days, washed three times in 0.0 1 M phosphatebuffered saline, pH 7-4 (PBS), and resuspended in Tyrode's buffer.'l Sonicated bacteria were prepared by sonication on ice, three times for 2 min at an amplitude of 18 pm (MSE Soniprep 150). These H. pylori preparations were used at a final protein concentration of 0.1 5 mg/ml, which was chosen as appropriate from the previously published work of Bechi et al.17 Hae. influenzae was harvested at 24 h, washed three times in PBS and resuspended in Tyrode's buffer. The bacteria were used in the histamine release assay at a final protein concentration of 0.15 mg/ml, as above.
Isolation of human basophils
Blood (30ml) was drawn by venepuncture, anticoagulated with heparin, and mixed with 5 ml of dextran 70 (Lomodex 70) and 150 mg of glucose. After sedimentation for 90 min, the supernate was collected. The cells were obtained by centrifugation (200 g, 7min, 20"C), and washed twice in Tyrode's buffer. The basophils were pre-incubated at 37°C for 10 min before challenge.
Isolation of rat peritoneal mast cells
Mixed peritoneal cells were isolated from female Hooded Lister rats by direct lavage with heparinised Tyrode's buffer as described previously. 21 The mast cell suspensions were pre-warmed for 5 min at 37°C before challenge.
Histamine release assay
Mast cells or basophils were incubated, for 10 and 45 min, respectively, with the various bacterial preparations alone, or in the presence of several known immunological or non-immunological stimulants (as described in the Results). All samples were incubated, in duplicate, at 37°C within a metabolic shaker. The reactions were stopped by placing the tubes in an icewater bath and the addition of ice-cold Tyrode's buffer. The cells were recovered by centrifugation, and the histamine concentration was assayed in both the cellular and the supernatant (released histamine) fractions. Histamine was measured by an automated fluorimetric assay based on the method of Shore et ~1 .~~9~ ' Histamine release was expressed as a percentage of the total histamine (cells and supernates) and corrected for the spontaneous release (i.e., that occurring in the absence of a stimulant). In several experiments, the effects of H. pylori preparations on histamine release were expressed as percentage inhibition. This was calculated from the formula : 
Results
In the initial experiments, whole washed bacteria of 11 different strains of H. pylori were tested. None of the strains elicited a significant histamine release from rat peritoneal mast cells when tested alone and, therefore, two H. pylori strains (HP1 and HP2) were selected for the further experiments. release induced by calcium ionophore A23187. The membrane preparations and LPS extracts of H . pylori inter-strain variation in this inhibition of histamine (HP 1) were examined. Minimal histamine release was release by H . pylori is illustrated in fig. 2. induced (< 10 %) when these preparations were The effects of formalin-killed bacteria, outerincubated alone with rat peritoneal mast cells (data fig. 4) . With human basophils, no significant histamine release ( < 3 YO) was induced when formalin-killed preparations or LPS extracts of H. pylori (HP1) were incubated alone with these cells (data not shown). These preparations inhibited histamine release from human basophils induced by calcium ionophore A23 187 and N-formyl Met-Leu-Phe ( fig. 5) . H . pylori outer-membrane preparations (10 ng of protein/ml) caused a slight but significant inhibition (17%) of A23 187-induced histamine release but higher concentrations were not tested.
H . P YLO RI AND HISTAMINE RELEASE
No significant histamine release was obtained when whole washed Hae. injluenzae were incubated alone with rat peritoneal mast cells. The histamine release induced by calcium ionophore A23 187 (0.25 ,UM) was approximately doubled (from 13 YO to 23%) by co-incubation with Hae. injluenzae (0.15 mg of pro tein/ml).
Discussion
Histamine plays an essential role in the regulation of gastric acid ~ecretion.~' Factors that stimulate the production or liberation of histamine may contribute to the pathogenesis of duodenal ulcer disease, which is characterised by gastric hypersecretion. H. pylori is known to be an important pathogen in duodenal ulcer disease;30 however, the influence of H. pylori on mast cell and basophil histamine release remains unclear.
Previous findings'', l8 that histamine liberation does not occur when whole washed, whole formalin-killed or crude cell-envelope extracts of H. pylori are incubated in vitro with rat peritoneal mast cells were confirmed. This work was extended and it was found that, in addition, histamine release was not induced when rat peritoneal mast cells were exposed to LPS or outer-membrane extracts of H. pylori. Furthermore, in similar experiments with human basophils, histamine release was not stimulated by incubation with LPS or whole formalin-killed H. pylori preparations. However, in contrast to previous r e p o r t~,~~.~~ each of the five H. pylori preparations studied was shown to inhibit the release of histamine from rat peritoneal mast cells simultaneously stimulated by calcium ionophore A23 187 or compound 48/80. Inhibition was consistently obtained with whole washed bacteria of each of 11 different clinical isolates of H. pylori. The Italian workers found that co-incubation of purified rat peritoneal mast cells with several strains of H. pylori (whole washed, whole formalin-killed or crude cell-envelope preparations) and calcium ionophore A23187 or compound 48/80, caused a marked potentiation of histamine re1ea~e.l~. l8 In the present study, inhibition of histamine release from rat peritoneal mast cells was also seen with other stimulants (anti-rat IgE, concanavalin A) and with an additional cell type, the human basophil (calcium ionophore A23 187, N-formyl Met-Leu-Phe). Where possible, the concentration of bacterial preparations used was one that produced potentiation in previous studies.l7. l8 This inconsistency in the modulatory effects of H. pylori preparations on histamine release may reflect variations between the strains of H. pylori isolated in two different countries (Italy17* l8 and Northern Ireland). It is known that there is considerable genetic variation between different isolates of H. p y l~r i .~~, 32 The modulatory effect of H . pylori was found previously to differ between strains and, in some strains, no significant potentiation of histamine release was obtained.17 However, in the present study inhibition of histamine liberation was obtained with each of 11 different clinical isolates of H. pylori (48-97% inhibition). Although, in the current study, unpurified target cell populations were used, it is unlikely that the different effect was due to problems associated with either the cells or test systems examined, as potentiation of histamine liberation from rat peritoneal mast cells was achieved after co-incubation with calcium ionophore A23 187 and Hae. injluenzae. This is in agreement with a previous study in which calcium ionophore A23 187 enhanced histamine release from human basophils after stimulation with endotoxin from Hae. injlue~1zae.l~
The differences observed in the action of H. pylori preparations may also be due to the isolation procedures for the rat peritoneal mast cells. In the present study the cells were not purified, as marked functional alterations can occur after purification by density gradient methods. 33 In contrast, in the previously reported work, cell preparations purified by density gradient centrifugation and elutriation were used. 17* l8
Variation in the modulatory potential of H . pylori may reflect differences employed in the in-vitro growth conditions of the bacterium. H. pylori was harvested from solid culture media in the present study, whereas previous investigations were performed with broth c~l t u r e s .~~~~* H. pylori strains cultured on a solid medium synthesise Paf-acether, whereas the same isolates cultured in brucella broth do not.34 Therefore, it would be of interest to compare directly the ability of H. pylori isolates grown under different conditions to modulate mediator release.
Investigations of the interactions of H . pylori with the host cellular immune system have shown an increase in the expression of class I1 transplantation antigens and in the proportion of y / 6 T cells in H. pylori-infected compared to non-infected m u c o~a .~~, 36 Stimulation of mononuclear cells,37 cytokine production (IL-2, IL-4, IL-6, TNFa) and soluble CD8 and IL-2 receptor molecule production have been demonstrated in In contrast, H. pylori has been found to exert a down-regulating or inhibitory effect on cells involved in the mucosal defences. This includes a reduction in the in-vitro proliferative response of monocytes to stimuli, without altering cell viability.*O T lymphocyte proliferation is also inhibited and this is associated with a reduction of IL-2 receptor expre~sion.~~ This, together with the current findings that H . pyluri inhibits histamine release from mast cells and basophils, may support the theory that the persistence of H . pyluri infection is related to modulation of the host immune system by this bacterium. Differences in the ability of various H . pyluri strains to influence the host immune response influence the outcome of infection. Furthermore, the environmental conditions within the host tissues and the immune status of the host may influence the expression of virulence determinants by the infecting bacterium. Hence the outcome of infection (chronic gastritis or duodenal ulceration) may reflect a complex series of interactions between the host and the infecting bacterium.
In the present study, H . pyluri has been shown to inhibit histamine release from rat peritoneal mast cells and human basophils. Further studies are necessary to determine the role of this bacterium in the modulation of histamine release from human mucosal mast cells.
